Evidence map›Paper›PMID 34853312›Full record

ArticleNature communications2021

SPEN is required for Xist upregulation during initiation of X chromosome inactivation.

Teresa Robert-Finestra, Beatrice F Tan, Hegias Mira-Bontenbal, Erika Timmers, Cristina Gontan, Sarra Merzouk, Benedetto Daniele Giaimo, François Dossin, Wilfred F J van IJcken, John W M Martens and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Xist in X chromosome inactivation: mechanisms and disease relevance.Cell communication and signaling : CCS · 2025
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. The in vivo effects of knockdown of long non-coding RNA XIST on fibroid growth and gene expression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Teresa Robert-FinestraDepartment of Developmental Biology, Erasmus University Medical Center, Oncode Institute, 3015GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0220-8748
Beatrice F Tan *Department of Developmental Biology, Erasmus University Medical Center, Oncode Institute, 3015GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-6362-7474
Hegias Mira-Bontenbal *Department of Developmental Biology, Erasmus University Medical Center, Oncode Institute, 3015GD, Rotterdam, The Netherlands.
Erika Timmers *Department of Developmental Biology, Erasmus University Medical Center, Oncode Institute, 3015GD, Rotterdam, The Netherlands.
Cristina GontanDepartment of Developmental Biology, Erasmus University Medical Center, Oncode Institute, 3015GD, Rotterdam, The Netherlands.
Sarra MerzoukDepartment of Developmental Biology, Erasmus University Medical Center, Oncode Institute, 3015GD, Rotterdam, The Netherlands.
Benedetto Daniele GiaimoInstitute of Biochemistry, University of Giessen, 35392, Giessen, Germany.
François DossinEuropean Molecular Biology Laboratory, Director's Research, 69117, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-4085-1446
Wilfred F J van IJckenCenter for Biomics, Erasmus University Medical Center, 3015CN, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0421-8301
John W M MartensDepartment of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, 3015CN, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-3428-3366
Tilman BorggrefeInstitute of Biochemistry, University of Giessen, 35392, Giessen, Germany.
Edith HeardEuropean Molecular Biology Laboratory, Director's Research, 69117, Heidelberg, Germany.ORCID http://orcid.org/0000-0001-8052-7117
Joost GribnauDepartment of Developmental Biology, Erasmus University Medical Center, Oncode Institute, 3015GD, Rotterdam, The Netherlands. j.gribnau@erasmusmc.nl.ORCID http://orcid.org/0000-0001-5645-4691
Erasmus MC · NLEuropean Molecular Biology Laboratory · DEJustus-Liebig-Universität Gießen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At initiation of X chromosome inactivation (XCI), Xist is monoallelically upregulated from the future inactive X (Xi) chromosome, overcoming repression by its antisense transcript Tsix. Xist recruits various chromatin remodelers, amongst them SPEN, which are involved in silencing of X-linked genes in cis and establishment of the Xi. Here, we show that SPEN plays an important role in initiation of XCI. Spen null female mouse embryonic stem cells (ESCs) are defective in Xist upregulation upon differentiation. We find that Xist-mediated SPEN recruitment to the Xi chromosome happens very early in XCI, and that SPEN-mediated silencing of the Tsix promoter is required for Xist upregulation. Accordingly, failed Xist upregulation in Spen

Indexed as

X Chromosome InactivationAnimalsCell DifferentiationChromatin Assembly and DisassemblyDNA-Binding ProteinsFemaleGene Expression Regulation, DevelopmentalGenes, X-LinkedMaleMiceMice, Inbred C57BLMice, KnockoutMouse Embryonic Stem CellsPromoter Regions, GeneticRNA-Binding ProteinsRNA, Long NoncodingDNA-Binding ProteinsRNA-Binding ProteinsRNA, Long NoncodingSpen protein, mouseXIST non-coding RNA

Identifiers

PMID34853312
PMCPMC8636516
OpenAlexW3215829216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.